Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.
暂无分享,去创建一个
R. Diasio | J. Sparano | R. Zhang | S. Wadler | E. Schwartz | A. Einzig | P. Wiernik | Z. Lu